4.2 Review

Intentional weight loss in older adults: useful or wasting disease generating strategy?

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCO.0b013e32835f503f

关键词

obesity; older adults; physical activity; restrictive diet; sarcopenia

向作者/读者索取更多资源

Purpose of review Strategies for weight management in older adults remain controversial as overweight may protect them against mortality whereas weight loss may have harmful effects by promoting sarcopenia and bone loss. It has been suggested that weight management for obese older adults should focus more on maintaining weight and improving physical function than promoting weight loss. This review aims to specify whether intentional weight loss in older adults is a useful or a wasting disease generating strategy. Recent findings Recent randomized controlled studies have shown that a supervised, moderate caloric restriction coupled with regular exercise (both aerobic and resistance) in obese older adults do not increase mortality risk and may conversely reduce insulin resistance, metabolic complications, and disabilities without exacerbating lean mass and bone mineral density loss. Summary In obese older adults, moderate weight loss may have beneficial effects on comorbidities, functional performances, and quality of life provided that regular physical activity can be associated. An individual approach considering life expectancy, chronic comorbidities, functional status, personal motivation, and social support should be preferred. More research is needed to define the circumstances in which cautious dietary restrictions are reasonably justified in older adults. In any case, in the oldest (>= 80 years) as in frail individuals, it seems reasonable to abstain from recommending weight loss.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Endocrinology & Metabolism

Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?

A. -L. Borel, R. Tamisier, P. Bohme, P. Priou, A. Avignon, P. -Y. Benhamou, H. Hanaire, J. -L. Pepin, L. Kessler, P. Valensi, P. Darmon, F. Gagnadoux

DIABETES & METABOLISM (2019)

Article Respiratory System

Reprint of: Management of obstructive sleep apnea syndrome in people living with diabetes: context, screening, indications and treatment modalities: context, screening, indications and treatment modalities: a French position statement

A. -L. Borel, R. Tamisier, P. Bohme, P. Priou, A. Avignon, P. -Y. Benhamou, H. Hanaire, J. -L. Pepin, L. Kessler, P. Valensi, P. Darmon, F. Gagnadoux

REVUE DES MALADIES RESPIRATOIRES (2018)

Editorial Material Endocrinology & Metabolism

Assessment of the benefit-risk balance of SGLT2 inhibitors: Commentary on a new 'French paradox'

A. J. Scheen, P. Darmon, H. Hanaire, B. Bauduceau, L. Bordier, G. Chabrier, B. Charbonnel, B. Detournay, P. Fontaine, P. Gourdy, A. Grimaldi, B. Guerci, A. Pernfornis, J. P. Riveline

DIABETES & METABOLISM (2019)

Editorial Material Cardiac & Cardiovascular Systems

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials Perspective on GLP-1 RA and SGLT-2i therapies

Lisa Ludwig, Patrice Darmon, Bruno Guerci

CARDIOVASCULAR DIABETOLOGY (2020)

Article Endocrinology & Metabolism

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, Matthieu Pichelin, Abdallah Al-Salameh, Ingrid Allix, Coralie Amadou, Gwenaelle Arnault, Florence Baudoux, Bernard Bauduceau, Sophie Borot, Muriel Bourgeon-Ghittori, Olivier Bourron, David Boutoille, France Cazenave-Roblot, Claude Chaumeil, Emmanuel Cosson, Sandrine Coudol, Patrice Darmon, Emmanuel Disse, Amelie Ducet-Boiffard, Benedicte Gaborit, Michael Joubert, Veronique Kerlan, Bruno Laviolle, Lucien Marchand, Laurent Meyer, Louis Potier, Gaetan Prevost, Jean-Pierre Riveline, Rene Robert, Pierre-Jean Saulnier, Ariane Sultan, Jean-Francois Thebaut, Charles Thivolet, Blandine Tramunt, Camille Vatier, Ronan Roussel, Jean-Francois Gautier, Pierre Gourdy

DIABETOLOGIA (2020)

Correction Endocrinology & Metabolism

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study (vol 15, pg 631, 2020)

Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, Matthieu Pichelin, Abdallah Al-Salameh, Ingrid Allix, Coralie Amadou, Gwenaelle Arnault, Florence Baudoux, Bernard Bauduceau, Sophie Borot, Muriel Bourgeon-Ghittori, Olivier Bourron, David Boutoille, France Cazenave-Roblot, Claude Chaumeil, Emmanuel Cosson, Sandrine Coudol, Patrice Darmon, Emmanuel Disse, Amelie Ducet-Boiffard, Benedicte Gaborit, Michael Joubert, Veronique Kerlan, Bruno Laviolle, Lucien Marchand, Laurent Meyer, Louis Potier, Gaetan Prevost, Jean-Pierre Riveline, Rene Robert, Pierre-Jean Saulnier, Ariane Sultan, Jean-Francois Thebaut, Charles Thivolet, Blandine Tramunt, Camille Vatier, Ronan Roussel, Jean-Francois Gautier, Pierre Gourdy

DIABETOLOGIA (2020)

Editorial Material Endocrinology & Metabolism

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study

Matthieu Wargny, Pierre Gourdy, Lisa Ludwig, Dominique Seret-Begue, Olivier Bourron, Patrice Darmon, Coralie Amadou, Matthieu Pichelin, Louis Potier, Charles Thivolet, Jean-Francois Gautier, Samy Hadjadj, Bertrand Cariou

DIABETES CARE (2020)

Letter Endocrinology & Metabolism

Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Juni P et al [letter]

Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, Matthieu Pichelin, Abdallah Al-Salameh, Ingrid Allix, Coralie Amadou, Gwenaelle Arnault, Florence Baudoux, Bernard Bauduceau, Sophie Borot, Muriel Bourgeon-Ghittori, Olivier Bourron, David Boutoille, France Cazenave-Roblot, Claude Chaumeil, Emmanuel Cosson, Sandrine Coudol, Patrice Darmon, Emmanuel Disse, Amelie Ducet-Boiffard, Benedicte Gaborit, Michael Joubert, Veronique Kerlan, Bruno Laviolle, Lucien Marchand, Laurent Meyer, Louis Potier, Gaetan Prevost, Jean-Pierre Riveline, Rene Robert, Pierre-Jean Saulnier, Ariane Sultan, Jean-Francois Thebaut, Charles Thivolet, Blandine Tramunt, Camille Vatier, Ronan Roussel, Jean-Francois Gautier, Pierre Gourdy

DIABETOLOGIA (2020)

Article Medicine, General & Internal

Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study

Adele Lasbleiz, Bertrand Cariou, Patrice Darmon, Astrid Soghomonian, Patricia Ancel, Sandrine Boullu, Marie Houssays, Fanny Romain, Jean Christophe Lagier, Mohamed Boucekine, Noemie Resseguier, Pierre Gourdy, Matthieu Pichelin, Matthieu Wargny, Anne Dutour, Benedicte Gaborit

JOURNAL OF CLINICAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study

B. Gaborit, P. Ancel, A. E. Abdullah, F. Maurice, I. Abdesselam, A. Calen, A. Soghomonian, M. Houssays, I. Varlet, M. Eisinger, A. Lasbleiz, F. Peiretti, C. E. Bornet, Y. Lefur, L. Pini, S. Rapacchi, M. Bernard, N. Resseguier, P. Darmon, F. Kober, A. Dutour

Summary: Empagliflozin effectively reduced liver fat in mice and humans without impacting myocardial fat or myocardial energetics, contradicting the thrifty substrate hypothesis for cardiovascular protection of SGLT2 inhibitors.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Endocrinology & Metabolism

Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study

Ronan Roussel, Patrice Darmon, Matthieu Pichelin, Thomas Goronflot, Yawa Abouleka, Leila Ait Bachir, Ingrid Allix, Deborah Ancelle, Sara Barraud, Lyse Bordier, Aurelie Carlier, Nicolas Chevalier, Christine Coffin-Boutreux, Emmanuel Cosson, Anne Dorange, Olivier Dupuy, Pierre Fontaine, Benedicte Fremy, Florence Galtier, Natacha Germain, Anne-Marie Guedj, Etienne Larger, Stephanie Laugier-Robiolle, Bruno Laviolle, Lisa Ludwig, Arnaud Monier, Nathanaelle Montanier, Philippe Moulin, Isabelle Moura, Gaetan Prevost, Yves Reznik, Nadia Sabbah, Pierre-Jean Saulnier, Pierre Serusclat, Camille Vatier, Matthieu Wargny, Samy Hadjadj, Pierre Gourdy, Bertrand Cariou

Summary: A study on 2449 type 2 diabetes patients with COVID-19 found no significant association between the use of DPP-4 inhibitors and disease severity. Therefore, it is safe to continue using DPP-4 inhibitors for diabetes management during the COVID-19 pandemic.

DIABETES OBESITY & METABOLISM (2021)

Article Endocrinology & Metabolism

Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

Matthieu Wargny, Louis Potier, Pierre Gourdy, Matthieu Pichelin, Coralie Amadou, Pierre-Yves Benhamou, Jean-Baptiste Bonnet, Lyse Bordier, Olivier Bourron, Claude Chaumeil, Nicolas Chevalier, Patrice Darmon, Blandine Delenne, Delphine Demarsy, Marie Dumas, Olivier Dupuy, Anna Flaus-Furmaniuk, Jean-Francois Gautier, Anne-Marie Guedj, Nathalie Jeandidier, Etienne Larger, Jean-Philippe Le Berre, Myriam Lungo, Nathanaelle Montanier, Philippe Moulin, Francoise Plat, Vincent Rigalleau, Rene Robert, Dominique Seret-Begue, Pierre Serusclat, Sarra Smati, Jean-Francois Thebaut, Blandine Tramunt, Camille Vatier, Fritz-Line Velayoudom, Bruno Verges, Patrice Winiszewski, Audrey Zabulon, Pierre-Antoine Gourraud, Ronan Roussel, Bertrand Cariou, Samy Hadjadj

Summary: The study identified prognostic factors for hospital discharge and death in patients with diabetes hospitalized for COVID-19, finding that younger age, routine metformin therapy, longer symptom duration on admission were positively associated with discharge, while history of microvascular complications, anticoagulant routine therapy, dyspnoea on admission, and higher levels of certain biomarkers were associated with reduced chance of discharge.

DIABETOLOGIA (2021)

Article Cardiac & Cardiovascular Systems

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

Ofri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, Fahri Bayram, Patrice Darmon, Timothy M. E. Davis, Guillermo Dieuzeide, Kirsten T. Eriksen, Tianpei Hong, Margit S. Kaltoft, Csaba Lengyel, Nicolai A. Rhee, Giuseppina T. Russo, Shinichiro Shirabe, Katerina Urbancova, Sergio Vencio

Summary: The CAPTURE study aimed to estimate the prevalence of established cardiovascular disease in adults with type 2 diabetes across 13 countries from five continents, and to further characterize the study sample regarding demographics, clinical parameters, and medication usage, particularly focusing on glucose-lowering agents with demonstrated cardiovascular benefits.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database

Patrick Blin, Patrice Darmon, Patrick Henry, Estelle Guiard, Marie-Agnes Bernard, Caroline Dureau-Pournin, Helene Maizi, Florence Thomas-Delecourt, Regis Lassalle, Cecile Droz-Perroteau, Nicholas Moore

Summary: The study compared the efficacy of ticagrelor plus aspirin versus placebo plus aspirin for patients with stable coronary artery disease and type 2 diabetes mellitus, finding a prevalence of 1.5‰ for the THEMIS-like population in French practice, with a median age 5-6 years older than the study group, and significantly higher incidence rates of major outcomes over 2 years compared to the placebo arm of the THEMIS trial.

CARDIOVASCULAR DIABETOLOGY (2021)

Review Medicine, General & Internal

Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations

Thierry Hannedouche, Patrick Rossignol, Patrice Darmon, Jean-Michel Halimi, Patrick Vuattoux, Albert Hagege, Ludivine Videloup, Francis Guinard

Summary: Diabetes is the leading cause of end-stage kidney disease (ESKD), accounting for approximately 50% of patients starting dialysis. However, the management of patients with chronic kidney disease (CKD) remains poor, and there are fragmented care pathways among healthcare professionals (HCPs). Laboratory evidence, such as estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR), Kidney Failure Risk Equation (KFRE), and serum potassium, plays a crucial role in the diagnosis and monitoring of CKD and its complications.

POSTGRADUATE MEDICINE (2023)

暂无数据